Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.36 USD | -2.11% | -5.35% | +9.47% |
May. 21 | Ani Pharmaceuticals Insider Sold Shares Worth $794,568, According to a Recent SEC Filing | MT |
May. 20 | ANI Pharmaceuticals Launches Kionex Suspension | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.47% | 1.17B | |
+38.69% | 728B | |
+33.35% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.64% | 244B | |
+7.68% | 207B | |
-5.44% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- (ANIP) ANI PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $4.26 - $4.67